Home > Cannabis Research > Marijuana vs Alcohol

Marijuana vs Alcohol

A Comprehensive Health Comparison

Beyond "which is safer": an evidence-based, dimension-by-dimension comparison of the two most widely used psychoactive substances

95,000
Annual US Alcohol Deaths
CDC
~0
Cannabis-Only Overdose Deaths
LD50 ratio ~1000:1
22-30%
Cannabis Addiction Rate
vs. ~15% for alcohol
4-5x
Psychosis Risk (Cannabis Only)
Di Forti et al., 2019

"Is marijuana safer than alcohol?" is one of the most commonly asked questions in substance use. The honest answer: it depends on what you mean by "safer." Cannabis wins on some dimensions (toxicity, overdose risk), alcohol wins on others (psychosis, adolescent brain effects), and both lose on addiction, cognition, and driving. This page provides the complete, dimension-by-dimension comparison.

Schedule Consultation See the Comparison
Quick Answer: Marijuana vs Alcohol
More toxic?Alcohol. Approximately 95,000 annual US deaths. Cannabis-only overdose deaths are essentially zero.
More addictive?Cannabis: 22-30% of users develop CUD vs. ~15% for alcohol. However, alcohol withdrawal can be fatal; cannabis withdrawal cannot.
Worse for the brain?Different mechanisms. Alcohol causes more severe structural damage. Cannabis uniquely disrupts adolescent development and carries psychosis risk.
Bottom lineNeither is safe. The comparison should inform harm reduction, not justify use. The "safer than alcohol" argument is partially valid but dangerously incomplete.
ExpertRyan S. Sultan, MD -- NIH NIDA K12 researcher, Columbia University. JAMA Cardiology 2025 publication on cannabis cardiovascular effects.

On This Page

Head-to-Head Comparison Table
Toxicity & Overdose
Addiction Potential
Withdrawal Severity
Cognitive Effects

Mental Health Effects
Cardiovascular Effects
Driving Impairment
Adolescent Effects
Combined Use Risks
The "Safer" Argument Examined
FAQ

Head-to-Head Comparison: Cannabis vs. Alcohol

Dimension Cannabis (Marijuana) Alcohol
Overdose LethalityEssentially zero cannabis-only deaths. LD50 ratio ~1,000:1.~95,000 annual US deaths (CDC). LD50 is ~5-8 drinks/hour for an average adult.
Addiction Rate22-30% of users develop CUD (NIDA)~15% of drinkers develop AUD
Withdrawal DangerUncomfortable but not life-threateningCan be fatal (seizures, delirium tremens)
FDA-Approved TreatmentNone3+ (naltrexone, acamprosate, disulfiram)
Psychosis Risk4-5x increase (daily high-potency use)Only during withdrawal (alcoholic hallucinosis)
Brain DamageSelective, mostly reversible in adults. Adolescent effects may persist.Severe with heavy use (cortical atrophy, Wernicke-Korsakoff). Partially reversible.
Cardiovascular RiskTachycardia, emerging MI/stroke data (Sultan, JAMA Cardiology 2025)Cardiomyopathy, arrhythmias, hypertension
Cancer RiskUncertain (smoke contains carcinogens, but epidemiological evidence is inconsistent)Established carcinogen (oral, esophageal, liver, breast, colorectal)
Liver DamageMinimalSevere (fatty liver, hepatitis, cirrhosis)
Driving Impairment~2x crash risk. Impairs reaction time, divided attention.4-7x crash risk at 0.08 BAC. ~10,000 annual US traffic deaths.
Violence/AggressionGenerally reduces aggression acutelyMajor contributor to domestic violence, assault, homicide
Social HarmModerate (amotivation, social withdrawal, CUD)Severe (accidents, violence, family disruption, economic costs)
Adolescent RiskUnique neurodevelopmental risk (ECS disruption, psychosis, 1 in 6 CUD rate)Neurotoxic, especially binge drinking. Disrupts development.

Toxicity and Overdose: Cannabis Wins Decisively

On acute toxicity, cannabis is dramatically safer than alcohol. The lethal dose of alcohol is approximately 5-8 standard drinks consumed within one hour for an average adult (blood alcohol concentration of approximately 0.30-0.40%). Alcohol overdose kills approximately 2,200 Americans per year directly and contributes to 95,000 total deaths annually (CDC). These deaths include acute alcohol poisoning, alcohol-related liver disease, alcohol-attributable cancers, alcohol-related cardiovascular events, alcohol-impaired driving fatalities, alcohol-related violence and homicide, and alcohol-related falls and injuries. When all alcohol-attributable deaths are tallied, alcohol is the third-leading preventable cause of death in the United States after tobacco and poor diet/physical inactivity.

Cannabis has never had a confirmed lethal overdose in a human. The estimated LD50 (lethal dose for 50% of subjects) for THC is approximately 1,000 times a typical dose -- a ratio that makes fatal overdose essentially impossible through any normal route of administration. For comparison, the therapeutic index (ratio of lethal dose to effective dose) for alcohol is approximately 10:1, meaning it takes only about 10 times a "buzz" dose to potentially kill you. For cannabis, that ratio is estimated at approximately 1,000:1.

This is the strongest point in cannabis's favor and the foundation of the "safer than alcohol" argument. It is a legitimate and important difference. However, "not acutely lethal" is not the same as "safe," and the toxicity comparison tells only part of the story. Cannabis can produce medical emergencies that require treatment: severe anxiety and panic attacks that lead to emergency department visits, acute psychotic episodes requiring psychiatric hospitalization, cannabinoid hyperemesis syndrome (cyclical vomiting that can cause dehydration), cardiovascular events (tachycardia, arrhythmia, and in rare cases myocardial infarction), and impaired driving that leads to fatal motor vehicle accidents. The comparison should reduce alcohol's cultural normalization rather than generate false security about cannabis.

Addiction Potential: Cannabis Is More Addictive

This finding surprises many people: cannabis has a higher addiction rate than alcohol. Approximately 22-30% of cannabis users develop cannabis use disorder (NIDA; Hasin et al.), compared to approximately 15% of alcohol drinkers who develop alcohol use disorder. To put it differently: roughly 3 in 10 cannabis users become addicted, versus roughly 1 in 7 drinkers.

However, context matters. Because far more people drink alcohol than use cannabis, the absolute number of people with alcohol use disorder is much larger. And the consequences of alcohol addiction tend to be more medically severe -- alcohol withdrawal can produce seizures and death, while cannabis withdrawal is uncomfortable but not life-threatening.

Another critical difference: there are multiple FDA-approved medications for alcohol use disorder (naltrexone, acamprosate, disulfiram) and none for cannabis use disorder. This treatment gap means that once cannabis addiction develops, clinicians have fewer pharmacological tools available. For a deeper dive into cannabis addiction, see our cannabis addiction guide.

Withdrawal Severity: Alcohol Is More Dangerous

Alcohol withdrawal is one of the few substance withdrawals that can be fatal. Severe alcohol withdrawal can produce grand mal seizures, delirium tremens (DTs), autonomic instability, and death. Approximately 3-5% of patients who develop DTs die even with medical treatment. Alcohol withdrawal frequently requires medical supervision and sometimes ICU-level care.

Cannabis withdrawal, while clinically significant, is not medically dangerous. It produces irritability, insomnia, decreased appetite, anxiety, and physical symptoms (sweating, headaches) that peak around days 2-6 and resolve within 2-4 weeks. No one has ever died from cannabis withdrawal. However, the discomfort is real and is a major driver of relapse. For details, see our cannabis withdrawal guide.

Cognitive Effects: Different Mechanisms, Both Harmful

Both substances impair cognition, but through different mechanisms and with different patterns of damage and recovery. Understanding these differences is important for assessing the comparative risk profile of each substance across different use patterns and populations.

Alcohol produces dose-dependent cognitive impairment acutely (slurred speech, impaired judgment, memory blackouts) and severe, widespread brain damage with chronic heavy use. Alcoholic dementia, Wernicke-Korsakoff syndrome (irreversible thiamine-deficiency brain damage resulting from chronic thiamine depletion), cerebellar degeneration (producing permanent coordination deficits), and frontal lobe atrophy are well-documented consequences of chronic alcoholism. These effects are devastating and often only partially reversible. Alcohol is directly neurotoxic -- it damages neurons through oxidative stress, excitotoxicity (excessive glutamate release), and neuroinflammation. Even moderate chronic alcohol use has been associated with measurable brain volume reductions in population-level studies.

Cannabis produces more selective cognitive effects -- primarily targeting memory, attention, and executive function through the endocannabinoid system rather than causing widespread neurotoxicity. Chronic cannabis use impairs short-term memory encoding (hippocampal effects), processing speed, divided attention, and prefrontal cortex function (executive control, planning, and decision-making). The Dunedin Study suggested an 8-point IQ decline with persistent adolescent-onset use, though this finding remains debated (see our brain effects page for the full IQ debate). Cannabis cognitive effects are generally more reversible than alcohol-related damage. CB1 receptors normalize within approximately 28 days of abstinence, and most cognitive deficits show significant improvement within 1-3 months. The important exception: adolescent-onset cannabis use may produce more lasting cognitive effects, particularly on IQ and executive function, because THC disrupts brain development through the endocannabinoid system during a critical maturational window.

In clinical practice, the cognitive profiles of chronic alcohol users and chronic cannabis users look different. Alcoholic patients often present with global cognitive deficits -- impaired memory, attention, processing speed, and visuospatial ability. Cannabis patients more commonly present with selective deficits in memory and executive function, often with relatively preserved other cognitive domains. Both profiles impair real-world functioning, but the alcohol profile is typically more severe.

Mental Health Effects: Cannabis Has Unique Risks

Both substances worsen mental health with chronic use, but they do so through different mechanisms and with different risk profiles. This is one of the most important areas of comparison, and one where the simple "safer than alcohol" framework breaks down most clearly.

Psychosis: Cannabis's Unique Risk

Daily use of high-potency cannabis increases the risk of psychotic disorder 4-5 fold (Di Forti et al., 2019, Lancet Psychiatry). Cannabis-induced psychosis has the highest conversion rate to chronic schizophrenia of any substance-induced psychosis (34-50% within 3-5 years). This risk is dose-dependent and particularly elevated in adolescents and those with genetic vulnerability (COMT Val/Val, AKT1 C/C genotypes). A 2023 Danish study found that cannabis use disorder was associated with approximately 30% of schizophrenia diagnoses in young men. Alcohol does not carry this risk -- alcoholic hallucinosis occurs only during severe withdrawal and is a different phenomenon entirely. For a comprehensive review, see our cannabis and psychosis guide.

Depression and Anxiety

Both substances are associated with increased depression and anxiety with chronic use, but through different mechanisms. Alcohol is a central nervous system depressant that directly suppresses neural activity, worsens depression through GABAergic and serotonergic disruption, and is heavily implicated in suicide (present in approximately 25-30% of completed suicides). Cannabis worsens depression and anxiety through endocannabinoid system depletion, dopamine system downregulation, and disrupted sleep architecture, as detailed in our cannabis and depression/anxiety guide.

Suicide

Both substances are associated with increased suicide risk. Alcohol is present in approximately 25-30% of completed suicides and is one of the strongest acute risk factors for suicidal behavior. Cannabis use in adolescence is associated with a 3.46-fold increased risk of suicide attempts in young adulthood (Gobbi et al., 2019, JAMA Psychiatry). Both substances impair the judgment and impulse control that normally prevent suicidal behavior, and both worsen the depression and hopelessness that drive suicidal ideation.

Cardiovascular Effects

Alcohol: Chronic heavy drinking causes alcoholic cardiomyopathy (weakened heart muscle), atrial fibrillation and other arrhythmias, and hypertension. The "French paradox" suggesting cardiovascular benefit from moderate wine consumption has been increasingly challenged by recent research suggesting that any level of alcohol consumption carries net cardiovascular risk.

Cannabis: Acutely increases heart rate by 20-50% within minutes, which can trigger cardiovascular events in vulnerable individuals. Our research -- including a 2025 publication in JAMA Cardiology -- has examined associations between cannabis use and cardiovascular events including myocardial infarction and stroke, particularly in younger users. Cannabis smoke contains many of the same combustion products as tobacco smoke and carries similar pulmonary and vascular risks when smoked. The cardiovascular effects of cannabis have been understudied relative to alcohol but are emerging as a significant concern.

Driving Impairment: Both Dangerous, Alcohol More So

Both substances impair driving, but alcohol is associated with greater impairment and more traffic fatalities. Alcohol at the legal limit (0.08 BAC) increases fatal crash risk approximately 4-7 fold and is implicated in approximately 10,000 annual US traffic deaths (NHTSA). Alcohol impairs reaction time, judgment, coordination, and risk assessment in a dose-dependent manner.

Cannabis approximately doubles the risk of a fatal crash (Asbridge et al., 2012, BMJ). It impairs reaction time, divided attention, lane tracking, and gap acceptance (judging whether it is safe to enter traffic or pass another vehicle). Interestingly, cannabis-impaired drivers often partially compensate by driving more slowly and maintaining greater following distances -- a behavior pattern not seen with alcohol, where impairment is accompanied by increased risk-taking.

The combination is the worst scenario. Using both cannabis and alcohol before driving produces additive impairment that exceeds either substance alone. States with legalized cannabis have seen increases in drivers testing positive for THC, often in combination with alcohol. A critical practical difference: alcohol has a well-established legal framework (BAC testing, per se limits) that enables enforcement. Cannabis lacks an equivalent -- THC can be detected in blood for days to weeks after use, making it difficult to determine acute impairment at the time of driving. This testing limitation complicates both enforcement and research on cannabis-impaired driving.

Another important consideration: the method of cannabis consumption affects driving risk. Smoking or vaping produces rapid-onset impairment that peaks within minutes and diminishes over 2-4 hours. Edibles have a delayed onset (30-90 minutes) and prolonged duration (4-8 hours), creating a longer window of impairment and making it more difficult for users to judge when they are safe to drive. The increasing popularity of edibles in legal markets adds a new dimension to the driving safety concern.

Adolescent Effects: Cannabis Has Unique Neurodevelopmental Risks

Both substances are harmful to the developing adolescent brain, but cannabis poses unique neurodevelopmental risks because it acts directly on the endocannabinoid system -- a system that guides brain maturation. Adolescent alcohol use, particularly binge drinking, is neurotoxic and disrupts hippocampal development and white matter maturation. But cannabis exposure during adolescence disrupts synaptic pruning, prefrontal cortex development, and dopamine system maturation through a mechanism (ECS disruption) that has no parallel with alcohol.

The psychosis risk is another uniquely cannabis-specific adolescent concern. Adolescent cannabis use, particularly before age 15, is associated with a 4-fold increase in schizophreniform disorder risk (Arseneault et al., 2002). Alcohol does not carry this risk. For adolescents specifically, the argument that cannabis is "safer than alcohol" is more problematic than for adults. The comparison may be reversed on some dimensions -- particularly neurodevelopmental disruption and psychosis risk -- where cannabis poses greater danger than alcohol to the developing brain.

Combined Use: Worse Than Either Alone

Concurrent use of cannabis and alcohol ("cross-fading") is common and dangerous. Important facts about combined use:

  • Alcohol increases THC absorption: Alcohol dilates blood vessels and increases THC absorption by approximately 2-fold (Hartman et al., 2015). The same amount of cannabis produces a much stronger effect when combined with alcohol.
  • Synergistic impairment: The combination produces greater impairment of driving, cognition, and coordination than either substance alone -- and the impairment may be more than additive (synergistic).
  • "Greening out": The combination significantly increases the risk of acute adverse reactions including severe nausea, vomiting, dizziness, anxiety, and loss of consciousness.
  • Emergency department data: Combined cannabis-alcohol presentations are associated with worse outcomes than either substance alone.
  • Cross-potentiation of addiction: Regular use of both substances increases the risk of developing a use disorder with either or both.
  • Adolescent risk: Combined use is particularly common among adolescents and young adults. In this population, the neurodevelopmental risks of each substance are compounded by concurrent exposure, and the executive function impairment that makes it difficult to moderate use is worsened by both substances acting on prefrontal circuits simultaneously.

From a clinical perspective, I treat many patients who use both cannabis and alcohol. This polydrug use pattern complicates treatment because both substances must be addressed simultaneously. Reducing one while continuing the other often leads to compensatory escalation -- the patient drinks more when they cut cannabis, or smokes more when they cut alcohol. Effective treatment requires a comprehensive approach that addresses the function both substances serve (stress relief, social facilitation, sleep aid, emotional avoidance) and develops alternative strategies for each.

The "Safer Than Alcohol" Argument: Examined Critically

The argument that cannabis is "safer than alcohol" is partially valid and partially misleading. Here is an honest assessment:

Where It Is Valid

  • Acute toxicity: Cannabis is dramatically less acutely lethal. This is an important fact.
  • Withdrawal danger: Cannabis withdrawal is uncomfortable; alcohol withdrawal can kill.
  • Violence: Alcohol is a major contributor to violence; cannabis generally is not.
  • Organ damage: Cannabis does not cause the liver, pancreatic, or gastrointestinal damage that alcohol causes.
  • Cancer: Alcohol is an established carcinogen; the evidence for cannabis is uncertain.

Where It Is Misleading

  • Addiction rate: Cannabis is actually more addictive per user than alcohol (22-30% vs. 15%).
  • Psychosis: Cannabis carries a major psychosis risk that alcohol does not. This is particularly dangerous for adolescents and genetically vulnerable individuals.
  • Treatment: There are FDA-approved medications for alcohol addiction; there are none for cannabis addiction.
  • Adolescent brain: Cannabis uniquely disrupts brain development through the ECS in ways that alcohol does not.
  • "Safer" implies "safe": The comparison is often used to justify cannabis use, when the appropriate conclusion is that both substances carry serious risks.

My Position: As a researcher and clinician, I am not interested in declaring a "winner" in the marijuana vs. alcohol comparison. Both substances cause substantial harm. The comparison should be used to develop evidence-based harm reduction policies -- including honest public education about the risks of both substances, potency regulation for cannabis, better treatment options for both disorders, and preventing adolescent use of both -- not to justify the use of either. "Less harmful than alcohol" is a low bar that neither patients nor policy should aspire to clear. The appropriate public health goal is to minimize harm from both substances, not to use the harms of one to normalize the other.

Frequently Asked Questions

Q: Is marijuana safer than alcohol?

A: On acute toxicity: yes, dramatically. Cannabis-only overdose deaths are essentially zero vs. 95,000 annual US alcohol deaths. On addiction: no -- cannabis is more addictive (22-30% vs. 15%). On psychosis: no -- cannabis carries unique psychosis risk. On adolescent brain effects: cannabis has unique ECS-mediated neurodevelopmental risks. The honest answer is that neither is safe, and the comparison should inform policy rather than justify use.

Q: Which is more addictive?

A: Cannabis, by percentage of users. 22-30% of cannabis users develop CUD vs. approximately 15% of drinkers who develop AUD. However, alcohol addiction has worse medical consequences (fatal withdrawal) and better treatment options (3+ FDA-approved medications vs. none for cannabis).

Q: Is it safe to mix marijuana and alcohol?

A: No. Alcohol increases THC absorption by approximately 2x. The combination produces synergistic impairment, increases "greening out" risk, and is associated with more emergency department visits than either substance alone.

Q: Which is worse for the brain?

A: Different mechanisms. Alcohol causes more severe structural damage with heavy, chronic use. Cannabis produces more selective, generally more reversible effects but uniquely disrupts adolescent brain development and carries psychosis risk. For adolescents, cannabis may pose greater neurodevelopmental risk.

Q: Which is worse for driving?

A: Alcohol. It increases fatal crash risk 4-7x at the legal limit and causes approximately 10,000 annual US traffic deaths. Cannabis approximately doubles crash risk. Both are dangerous. The combination is worse than either alone.

Q: Does marijuana cause cardiovascular problems?

A: Emerging evidence suggests yes. Cannabis acutely increases heart rate 20-50% and has been associated with cardiovascular events. Dr. Sultan's 2025 JAMA Cardiology publication examines cannabis cardiovascular effects. Cannabis smoke contains combustion products similar to tobacco smoke. The cardiovascular risks of cannabis are a growing area of concern.

Related Resources

Marijuana vs Alcohol (Quick Reference)

Shorter comparison for quick reference.

Quick Comparison →

Cannabis Brain Effects

Detailed neuroscience of how cannabis affects the brain.

Brain Effects →

Cannabis & Mental Health Hub

Complete cannabis research hub.

Cannabis Hub →

Concerned About Cannabis or Alcohol Use?

Dr. Ryan Sultan provides evidence-based evaluation and treatment for both cannabis and alcohol use disorders. Board-certified in adult and child/adolescent psychiatry.

Schedule a Consultation

Telehealth appointments available | Board-Certified Psychiatrist | Columbia University Faculty

Cannabis Research

Cannabis Hub
Cannabis Use Disorder
Is Cannabis Addictive?
Cannabis & Psychosis

Brain & Health

Cannabis & Teen Brain
Brain Effects
THC Potency
Cannabis Withdrawal

Dr. Sultan

Home
Research
PAWS Project
Clinical Practice

Contact

Schedule Consultation
ADHD Resources
Columbia University Irving Medical Center

© 2026 Ryan S. Sultan, MD | Assistant Professor of Clinical Psychiatry, Columbia University Irving Medical Center

The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.